Pa. Xarelto Plaintiffs Request to Amend Master Complaint
Pa. Xarelto Plaintiffs Request to Amend Master Complaint
Introduction
More than 1,800 product liability claims involving Johnson & Johnson and its subsidiary Janssen Pharmaceuticals’ blood thinner Xarelto are awaiting trial in Philadelphia Court of Common Pleas, and trials for three Xarelto lawsuits are expected to begin this April.
A request to make changes to the Master Complaint was put before the Philadelphia Court of Common Pleas by the remaining Pennsylvania plaintiffs to give them time to “reorganize the allegations and provide more details about the actions and inactions that form the bases of already-existing causes of action.” This request is strongly opposed by the defendants.
There are nearly 18,000 Xarelto federal product liability claims consolidated under MDL No.- 2592 in the U.S. District Court for the Eastern District of Louisiana.
Comments
Latest News
Zimmer Biomet Gets FDA Approval for Cementless Partial Knee
Categories: Zimmer Hip/Knee Replacement
Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…
Court Names Special Masters for Bard Mesh Claim Settlements
Categories: Hernia Mesh
The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…
Baltimore Wins $266M in Opioid Case Against Drug Distributors
Categories: Opioids
Baltimore has secured a $266 million victory in its lawsuit against major drug distributors McKesson and Cencora (formerly AmerisourceBergen), accusing them of fueling the…